SREBF2 and steatosis: Particularly, liver disease severity seems to be strongly related to dysregulation of SREBP-2 as animal and clinical studies have demonstrated that alterations in transcriptional regulators of cholesterol homeostasis mediate the progression of steatosis to steatohepatitis [37–39].